296 related articles for article (PubMed ID: 30566494)
1. Prevalence, incidence and residual risk of transfusion-transmitted HBV infection before and after the implementation of HBV-NAT in northern Brazil.
Corrêa ASM; Lamarão LM; Vieira PCM; de Castro RBH; de Almeida NCC; de Castro JAA; de Lima MSM; Palmeira MK; Meireles ALLP; Burbano RR
PLoS One; 2018; 13(12):e0208414. PubMed ID: 30566494
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus testing by minipool nucleic acid testing: does it improve blood safety?
Stramer SL; Notari EP; Krysztof DE; Dodd RY
Transfusion; 2013 Oct; 53(10 Pt 2):2449-58. PubMed ID: 23607261
[TBL] [Abstract][Full Text] [Related]
3. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?
Stramer SL; Zou S; Notari EP; Foster GA; Krysztof DE; Musavi F; Dodd RY
Transfusion; 2012 Feb; 52(2):440-6. PubMed ID: 21810101
[TBL] [Abstract][Full Text] [Related]
4. Enhanced detection of hepatitis B virus in Hong Kong blood donors after introduction of a more sensitive transcription-mediated amplification assay.
Tsoi WC; Lelie N; Lin CK
Transfusion; 2013 Oct; 53(10 Pt 2):2477-88. PubMed ID: 23521050
[TBL] [Abstract][Full Text] [Related]
5. Characteristic of HBV nucleic acid amplification testing yields from blood donors in China.
Wu D; Wang X; Feng F; Wang D; Hu Y; Yu Y; Huang J; Wang M; Dong J; Wu Y; Zhu H; Zhu F
BMC Infect Dis; 2021 Jul; 21(1):714. PubMed ID: 34330225
[TBL] [Abstract][Full Text] [Related]
6. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?
Busch MP
Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546
[TBL] [Abstract][Full Text] [Related]
7. [Trends in residual risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2002 and impact of viral genome screening (Nucleic Acid Testing)].
Pillonel J; Laperche S; ; ;
Transfus Clin Biol; 2004 Apr; 11(2):81-6. PubMed ID: 15120104
[TBL] [Abstract][Full Text] [Related]
8. Anti-HBc screening - is it worth the effort? Results of a 10-year surveillance programme covering more than 30 million donations in Germany.
Houareau C; Offergeld R
Vox Sang; 2019 Jul; 114(5):459-466. PubMed ID: 30968958
[TBL] [Abstract][Full Text] [Related]
9. Poor efficacy of nucleic acid testing in identifying occult HBV infection and consequences for safety of blood supply in Italy.
Spreafico M; Berzuini A; Foglieni B; Candotti D; Raffaele L; Guarnori I; Colli A; Maldini FF; Allain JP; Prati D
J Hepatol; 2015 Nov; 63(5):1068-76. PubMed ID: 26116791
[TBL] [Abstract][Full Text] [Related]
10. Nucleic acid amplification test: Bridging the gap in blood safety & re-evaluation of blood screening for cryptic transfusion-transmitted infection among Indian donors.
Datta S; Khillan K; Ranjan V; Wattal C
Indian J Med Res; 2019 Mar; 149(3):389-395. PubMed ID: 31249205
[TBL] [Abstract][Full Text] [Related]
11. Two cases of transfusion-transmitted hepatitis B virus (HBV) infection in a low-endemic country before implementation of HBV nucleic acid testing.
Servant-Delmas A; Chuteau C; Lefort C; Piquet Y; Chevaleyre S; Betbeze V; Delhoume M; Hantz S; Alain S; Laperche S
Transfusion; 2013 Feb; 53(2):291-6. PubMed ID: 22671296
[TBL] [Abstract][Full Text] [Related]
12. Nationwide nucleic acid amplification testing of hepatitis B virus, hepatitis C virus and human immunodeficiency virus type 1 for blood transfusion and follow-up study of nucleic acid amplification positive donors.
Japanese Red Cross NAT Screening Research Group
Jpn J Infect Dis; 2000 Jun; 53(3):116-23. PubMed ID: 10957709
[TBL] [Abstract][Full Text] [Related]
13. Detection of occult hepatitis B and window period infection among blood donors by individual donation nucleic acid testing in a tertiary care center in South India.
Keechilot CS; Shenoy V; Kumar A; Biswas L; Vijayrajratnam S; Dinesh K; Nair P
Pathog Glob Health; 2016; 110(7-8):287-291. PubMed ID: 27788631
[TBL] [Abstract][Full Text] [Related]
14. Residual risk of transmission of human immunodeficiency virus and hepatitis C virus infections by blood transfusion in northern Brazil.
Vieira PCM; Lamarão LM; Amaral CEM; Corrêa ASM; de Lima MSM; Barile KADS; de Almeida KLD; Sortica VA; Kayath AS; Burbano RMR
Transfusion; 2017 Aug; 57(8):1968-1976. PubMed ID: 28589643
[TBL] [Abstract][Full Text] [Related]
15. Blood donor testing for hepatitis B virus in the United States: is there a case for continuation of hepatitis B surface antigen detection?
Dodd RY; Nguyen ML; Krysztof DE; Notari EP; Stramer SL
Transfusion; 2018 Sep; 58(9):2166-2170. PubMed ID: 30144082
[TBL] [Abstract][Full Text] [Related]
16. Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window-phase donations not detected by NAT.
Weusten JJ; van Drimmelen HA; Lelie PN
Transfusion; 2002 May; 42(5):537-48. PubMed ID: 12084161
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of serologic markers for hepatitis B and C viruses in Brazilian blood donors and incidence and residual risk of transfusion transmission of hepatitis C virus.
de Almeida-Neto C; Sabino EC; Liu J; Blatyta PF; Mendrone-Junior A; Salles NA; Leão SC; Wright DJ; Basques FV; Ferreira JE; Busch MP; Murphy EL;
Transfusion; 2013 Apr; 53(4):827-34. PubMed ID: 22882510
[TBL] [Abstract][Full Text] [Related]
18. High rate of seromarkers for HIV, HBV and syphilis among blood donors using confidential unit exclusion, before and after HIV-NAT implementation at a major public blood bank in the Brazilian Amazon.
Souza JC; Crispim MAE; Abrahim C; Fraiji NA; Kiesslich D; Stefani MMA
Transfusion; 2019 Feb; 59(2):629-638. PubMed ID: 30499594
[TBL] [Abstract][Full Text] [Related]
19. NAT for HBV and anti-HBc testing increase blood safety.
Roth WK; Weber M; Petersen D; Drosten C; Buhr S; Sireis W; Weichert W; Hedges D; Seifried E
Transfusion; 2002 Jul; 42(7):869-75. PubMed ID: 12375659
[TBL] [Abstract][Full Text] [Related]
20. Routine screening of blood donations at Qingdao central blood bank, China, for hepatitis B virus (HBV) DNA with a real-time, multiplex nucleic acid test for HBV, hepatitis C virus, and human immunodeficiency virus Types 1 and 2.
Yang Z; Xu L; Liu L; Feng Q; Zhang L; Ma W; Saldanha J; Wang M; Zhao L
Transfusion; 2013 Oct; 53(10 Pt 2):2538-44. PubMed ID: 23480568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
